Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dongyao Wang, Ph.D.

Title
Institution
Department
Address
Profile Picture

Biography
Harvard Medical School, United StatesResearch fellowTumor immnology
University of Science and Technology of China, ChinaAssociate research fellowTumor immnology
University of Science and Technology of China, ChinaPostdoc12/2022Tumor immnology
University of Science and Technology of China, ChinaPhD06/2019Tumor immnology
Jilin University, ChinaBachelor of Medicine06/2013Medicine

Overview
Dongyao Wang received his PhD degree and completed postdoctoral work in immunology from the University of Science and Technology of China (USTC). His work demonstrated that pharmacologic inhibition of GARP-mediated active TGF signaling could restore NK cell-mediated graft-versus leukemia (GVL) activity. In addition, he demonstrated that sequential low-dose IL-2 therapy increased the frequency and function of HBV-specific CD8+ T cells, which contributed to HBeAg seroconversion, among the non-responder chronic hepatitis B patients after IFN therapy. Furthermore, he found that the inhibition of IL-11-STAT3 signaling could significantly suppress postsurgical recurrence of liver cancer. Dongyao is interested in the role of NK cells and in different kinds of tumors.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. 82370217 (Dongyao Wang) Jan 1, 2024 - Jan 31, 2027
    Natural Science Foundation of China
    The Mechanistic Study on L-Arginine Reversing Autophagy of NK Cells in the Bone Marrow Microenvironment of AML after Allogeneic Hematopoietic Stem Cell Transplantation and Restoring the GvL Effect
    Role: Investigator
  2. 82100230 (Dongyao Wang) Jan 1, 2022 - Dec 31, 2024
    Natural Science Foundation of China
    The Mechanistic Study on GARP Activation of TGF-ß1 Inhibiting the GvL Effect of Bone Marrow NK Cells after Allogeneic Hematopoietic Stem Cell Transplantation.
    Role: Investigator

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Wang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.